Shares of Nebius Group (NASDAQ:NBIS | NBIS Price Prediction) are down 13% in midday trading to $174, extending a rough stretch for the Amsterdam-based AI cloud specialist. The stock is down 36% over the past month.
The move caps a week of broad de-risking across the neocloud and AI data center trade. Nebius isn’t profitable, so it carries no P/E ratio to anchor its valuation, which leaves sentiment doing more of the price discovery than fundamentals.
Meta Overhang and an Asset-Light Pivot
The bear thread circulating today is that Meta Platforms (NASDAQ:META) could expand its own cloud infrastructure and increase competitive pressure on specialized AI cloud providers like Nebius. Nebius shares also sit below key moving averages, and there has been routine insider selling, which reads as normal executive liquidity rather than a red flag.
Working against that narrative, Nebius announced Wednesday (per Business Wire and Blockspace) an asset-light model in which infrastructure partners finance and own data centers while Nebius supplies its full-stack AI cloud platform, systems architecture, and sales. CEO Arkady Volozh stated that the structure gives Nebius’s partners “much better margins than conventional wholesale bare-metal contracts.” The company disclosed no financial targets, partners, or timelines.
Balancing the debate, Nebius still has an NVIDIA (NASDAQ:NVDA) $2 billion pre-funded warrant investment and a $12 billion committed Meta Platforms infrastructure services deal plus up to $15 billion in additional flexible capacity over five years, alongside $33.6 billion in remaining performance obligations.
How CoreWeave, IREN, and the Miner Pivots Stack Up
CoreWeave (NASDAQ:CRWV) is the closest pure-play comparison, carrying a $99.4 billion revenue backlog that includes a $21 billion Meta Platforms commitment. CoreWeave shares are down 28% over the past month, so the derating is not a Nebius-only story.
The miner-to-AI cohort has fared similarly. IREN (NASDAQ:IREN) landed a five-year, $3.4 billion NVIDIA AI cloud contract plus up to $2.1 billion in NVIDIA investment vesting toward 600,000 GPUs, yet IREN stock is down 37% over the past month. Core Scientific (NASDAQ:CORZ), TeraWulf (NASDAQ:WULF), and Applied Digital (NASDAQ:APLD) have all slid sharply as well, even though Applied Digital posted a fiscal Q3 2026 61% revenue beat and adjusted earnings per share of $0.09.
The key differentiator is financing. Nebius’s asset-light pivot contrasts with the capital-intensive, debt- and dilution-heavy, balance-sheet-owned models used by CoreWeave and the miner-pivot names, all of which fund GPU buildouts on their own books.
A Lower-Volatility Way to Play the Theme
For investors uncomfortable with single-stock neocloud exposure, the Global X Data Center and Digital Infrastructure ETF (NASDAQ:DTCR) offers a diversified alternative. Verified holdings show the ETF owns Applied Digital at 3.2% but doesn’t hold Nebius, CoreWeave, IREN, Core Scientific, or TeraWulf.
The fund skews heavily toward established data-center REITs, plus chipmakers like NVIDIA. That mix trades lower volatility for less direct AI compute leverage, and it still carries single-sector concentration risk since it isn’t leveraged and remains tied to one theme.
What to Watch
The bull case for Nebius rests on the asset-light announcement, the NVIDIA anchor stake, and a customer book that already includes Microsoft (NASDAQ:MSFT) and Meta Platforms. The bear case cites dilution risk, hyperscaler in-sourcing, and a valuation that leaves little room for execution slips.
Retail sentiment surrounding Nebius on Reddit held bullish to very bullish through the selloff day, with scores ranging 72 to 82, suggesting some traders view the drop as opportunistic. Options positioning skews more cautious, with the full-chain put/call ratio at 1.25.
Market watchers can check for whether Nebius stock holds $175 into the close and whether the peer names stabilize alongside it. Any follow-through selling in CoreWeave or the miner pivots could signal the neo-cloud derating has further to run. Given the high-beta profile across this cohort, modest position sizing should apply for anyone stepping in on weakness.
Contact [email protected] for any questions or corrections.